Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score.

Sestak, Ivana; Cuzick, Jack; Dowsett, Mitch; Lopez-Knowles, Elena; Filipits, Martin; Dubsky, Peter; Cowens, John Wayne; Ferree, Sean; Schaper, Carl; Fesl, Christian; Gnant, Michael

Sestak, Ivana; Cuzick, Jack; Dowsett, Mitch; Lopez-Knowles, Elena; Filipits, Martin; Dubsky, Peter; Cowens, John Wayne; Ferree, Sean; Schaper, Carl; Fesl, Christian; Gnant, Michael.

Affiliation

Sestak I; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Cuzick J; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Dowsett M; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Lopez-Knowles E; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Filipits M; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Dubsky P; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Cowens JW; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Ferree S; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Schaper C; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Fesl C; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W
Gnant M; Ivana Sestak, Jack Cuzick, Queen Mary University; Mitch Dowsett, Elena Lopez-Knowles, Royal Marsden Hospital, London, United Kingdom; Martin Filipits, Peter Dubsky, Michael Gnant, Medical University of Vienna; Christian Fesl, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; John W

J Clin Oncol ; 33(8): 916-22, 2015 Mar 10.

Article in En | MEDLINE | ID: mdl-25332252

Subject(s)

Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Neoplasm Recurrence, Local; Nitriles; Tamoxifen; Triazoles; Aged; Female; Humans; Middle Aged; Anastrozole; Antineoplastic Agents, Hormonal/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/pathology; Data Interpretation, Statistical; Follow-Up Studies; Hormones/therapeutic use; Kaplan-Meier Estimate; Neoplasm Recurrence, Local/diagnosis; Neoplasm Recurrence, Local/prevention & control; Nitriles/administration & dosage; Postmenopause; Prognosis; Proportional Hazards Models; Regression Analysis; Risk; Tamoxifen/administration & dosage; Time Factors; Treatment Outcome; Triazoles/administration & dosage; Austria

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Triazoles / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasm Recurrence, Local / Nitriles Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: J Clin Oncol Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google